Anavex Life Sciences Corp (AVXL)
P/OCF Ratio
-3.69×
TTM · Retrieved:

AVXL P/OCF Ratio
Current (TTM)-3.69×retrieved
Current (TTM)-3.69×retrieved
AVXL Quarterly P/OCF Ratio (-22099.45× → -17.50×)
Latest values, visible window
High-resolution chart · PNG
AVXL p/ocf ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | P/OCF Ratio |
|---|---|
| -17.499× | |
| -64.0799× | |
| -44.3218× | |
| -88.8487× | |
| -63.1586× | |
| -124.647× | |
| -75.1499× | |
| -71.6629× | |
| -67.0731× | |
| -35.5156× | |
| -104.4201× | |
| -89.3409× | |
| -85.9158× | |
| -79.0512× | |
| -124.6232× | |
| -196.272× | |
| -109.9022× | |
| -97.373× | |
| -376.4131× | |
| -177.2428× | |
| -214.5592× | |
| -140.1554× | |
| -44.1083× | |
| -46.771× | |
| -71.9042× | |
| -34.9266× | |
| -24.7792× | |
| -65.5241× | |
| -25.4025× | |
| -32.3196× | |
| -17.3719× | |
| -28.9791× | |
| -56.7279× | |
| -43.5833× | |
| -39.0326× | |
| -81.1328× | |
| -74.2533× | |
| -338.6042× | |
| -48.2112× | |
| -74.7987× | |
| -98.1147× | |
| -90.6956× | |
| -56.5269× | |
| -73.1285× | |
| -24.0307× | |
| -18.0402× | |
| -13.782× | |
| -8.2996× | |
| -14.3135× | |
| -43.9733× | |
| -20.6097× | |
| -50.2884× | |
| -526.0883× | |
| -166.0522× | |
| -181.5692× | |
| -102.0271× | |
| -118.7925× | |
| -299.3467× | |
| -29.9808× | |
| -54.8695× | |
| -48.2397× | |
| -153.8344× | |
| -81.714× | |
| -58.9346× | |
| -66.6281× | |
| -62.8721× | |
| -57.9096× | |
| -56.4407× | |
| -41.7753× | |
| -107.1726× | |
| -193.4467× | |
| -52.2987× | |
| -161.3388× | |
| -239.0788× | |
| -151.5421× | |
| -1,192.9942× | |
| -354.8476× | |
| -1,264.8732× | |
| -6,681.2734× | |
| -1,163.0443× | |
| 1,415.0422× | |
| -2,231.5202× | |
| -35,359.116× | |
| -1,869.4319× | |
| 0× | |
| -973.5074× | |
| -22,099.4475× |